The majority of the Company's sales contracts contain performance obligations satisfied at a point in time when title along with risks and rewards of ownership have transferred to the customer. This generally occurs when the product is shipped or accepted by the customer. Revenue for service contracts is recognized as the services are provided.
The majority of the Company's sales contracts contain performance obligations satisfied at a point in time when title along with risks and rewards of ownership have been transferred to the customer. This generally occurs when the product is shipped or accepted by the customer. Revenue for service contracts is recognized as the services are provided.
Management has analyzed the impact of the current economic climate on its financial statements as of December 31, 2024, and has determined that the changes to its significant judgements and estimates did not have a material impact with respect to goodwill, intangible assets, or long-lived assets.
Management has analyzed the impact of the current economic climate on its financial statements as of December 31, 2025, and has determined that the changes to its significant judgements and estimates did not have a material impact with respect to goodwill, intangible assets, or long-lived assets.
Considering the relatively short time between revenue recognition and receipt of payment, financing components do not exist between the Company and its customers. For contracts with customers that include multiple performance obligations, judgment is required to determine whether performance obligations specified in these contracts are distinct and should be accounted for as separate revenue transactions for recognition purposes.
Considering the relatively short time between revenue recognition and receipt of payment, financing components do not exist between the Company and its customers. 18 Table of Contents For contracts with customers that include multiple performance obligations, judgment is required to determine whether performance obligations specified in these contracts are distinct and should be accounted for as separate revenue transactions for recognition purposes.
Cash Flows Year Ended December 31, 2024, Compared to Year Ended December 31, 2023 Cash used by operating activities is net loss adjusted for certain non-cash items and changes in assets and liabilities.
Cash Flows Year Ended December 31, 2025, Compared to Year Ended December 31, 2024 Cash used by operating activities is net loss adjusted for certain non-cash items and changes in assets and liabilities.
Revenue Recognition The Company records revenue in accordance with FASB ASC Topic 606, “ Revenue from Contracts with Customers .” Revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
Revenue Recognition The Company records revenue in accord ance with FASB ASC Topic 606, “ Revenue from Contracts with Customers .” Revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
For the sale of aftermarket parts, the Company transfers control and recognizes revenue when parts are shipped to the customer. When customers are given the right to return eligible parts and accessories, the Company estimates the expected returns based on an analysis of historical experience.
Aftermarket sales represent spare parts, extended warranties, and maintenance services. For the sale of aftermarket parts, the Company transfers control and recognizes revenue when parts are shipped to the customer. When customers are given the right to return eligible parts and accessories, the Company estimates the expected returns based on an analysis of historical experience.
We discuss these policies further below as well as the estimates and judgments involved. Accounts Receivable and Allowance for Current Expected Credit Losses Accounts receivable consist of trade receivables arising from credit sales to customers in the normal course of business. These receivables are recorded at the time of sale, net of an allowance for current expected credit losses.
We discuss these policies further below as well as the estimates and judgments involved. 17 Table of Contents Accounts Receivable and Allowance for Current Expected Credit Losses Accounts receivable consist of trade receivables arising from credit sales to customers in the normal course of business.
Specifically, the deliveries of containerized oil and gas pilot systems to the Middle East and the U.S. contributed to lower-than-usual margins, reflecting a strategic decision aimed at demonstrating and validating the value proposition associated with our technology and seeding the market for future growth.
We did, however, continue to invest in deliveries of containerized oil and gas systems to the U.S., which contributed to lower-than-usual margins, reflecting a strategic decision aimed at demonstrating and validating the value proposition associated with our technology and seeding the market for future growth.
Warrant liabilities are recognized at fair value, with changes in fair value recognized in the consolidated statement of operations each period. Loss Contingencies We are subject to various legal and administrative proceedings along with asserted and potential claims, accruals related to product warranties, and potential asset impairments (loss contingencies) that arise in the ordinary course of business.
Loss Contingencies We are subject to various legal and administrative proceedings along with asserted and potential claims, accruals related to product warranties, and potential asset impairments (loss contingencies) that arise in the ordinary course of business.
Net cash used in investing activities was $424,036 for the year ended December 31, 2024, as compared to $2,886,036 for the year ended December 31, 2023, representing a decrease of $2,462,000.
Net cash used in investing activities was $217,930 for the year ended December 31, 2025, as compared to $424,036 for the year ended December 31, 2024, representing a decrease of $206,106.
For such arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are generally determined based on the prices charged to customers or using expected cost-plus margin. System sales are recognized when the Company transfers control to the customer based upon sales and delivery conditions specified in the sales contract.
For such arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are generally determined based on the prices charged to customers or using expected cost-plus margin.
Our most critical accounting estimates include: 26 Table of Contents ● The assessment of revenue recognition, which impacts revenue and cost of sales; ● The assessment of allowance for product warranties, which impacts cost of sales; ● The assessment of collectability of accounts receivable, which impacts operating expenses when and if we record bad debt or adjust the allowance for doubtful accounts; ● The assessment of recoverability of long-lived assets, which impacts gross margin or operating expenses when and if we record asset impairments or accelerate their depreciation; ● The recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions), which impact our provision for taxes; ● The valuation of inventory, which impacts cost of sales; and ● The recognition and measurement of loss contingencies, which impact cost of sales or operating expenses when we recognize a loss contingency, revise the estimate for a loss contingency, or record an asset impairment.
Our most critical accounting estimates include: ● The assessment of collectability of accounts receivable, which impacts operating expenses when and if we record bad debt or adjust the allowance for doubtful accounts; ● The valuation of inventory, which impacts cost of sales; ● The assessment of recoverability of long-lived assets, which impacts gross margin or operating expenses when and if we record asset impairments or accelerate their depreciation; ● The assessment of Contract assets, which impacts valuation of assets and revenue and cost when performance obligations have been satisfied; ● The assessment of revenue recognition, which impacts revenue and cost of sales; ● The assessment of stock-based awards, which impact operating expenses from the grant date throughout the vesting period; and ● The recognition and measurement of loss contingencies, which impacts cost of sales or operating expenses when we recognize a loss contingency, revise the estimate for a loss contingency, or record an asset impairment.
Contract assets also include unbilled receivables, which usually comprise the last invoice remaining after the delivery of the water treatment unit, where revenue is recognized at the transfer of control based upon signed acceptance of the unit by the customer.
Contract assets also include unbilled receivables, which usually comprise the last invoice remaining after the delivery of the system, where revenue is recognized at the transfer of control based upon signed acceptance of the unit by the customer. Most commonly, this invoice is sent to the customer at commissioning of the product or no later than 12 months after delivery.
The following is a summary of our non-cash compensation: 2024 2023 Compensation for vesting of restricted stock awards issued to the Board of Directors $ 202,125 $ 203,708 Compensation for vesting of restricted stock awards issued to management 462,309 424,196 Total Non-Cash Compensation $ 664,434 $ 627,904 Research and development expense for the year ended December 31, 2024, was $1,352,060 compared to $1,418,842 for the same period in 2023, representing a decrease of $66,782, or 4.7%.
The following is a summary of our non-cash compensation: 2025 2024 Compensation for vesting of restricted stock awards issued to the Board of Directors 271,256 $ 202,125 Compensation for vesting of restricted stock awards issued to management $ 715,816 462,309 Total Non-Cash Compensation $ 987,072 $ 664,434 Research and development expense for the year ended December 31, 2025, was $1,163,651 compared to $1,352,060 for the same period in 2024, representing a decrease of $188,409, or 13.9%.
For inventories produced, standard costs that approximate actual cost on the FIFO method are used to value inventories. Standard costs are reviewed at least annually by management or more often if circumstances indicate a change in cost has occurred. Work in process and finished goods include material, labor, and production overhead costs.
Standard costs are reviewed at least annually by management or more often if circumstances indicate a change in cost has occurred. Work in process and finished goods include material, labor, and production overhead costs. The Company adjusts the value of its inventories to the extent management determines that the cost cannot be recovered due to obsolescence or other factors.
The decline in gross profit was partly offset by decreased depreciation as well as continued initiatives aimed at optimizing manufacturing processes, which have improved profitability within DPF and ceramic membrane production. Included in the gross profit was depreciation of $1,830,553 and $2,598,095 for the years ended December 31, 2024, and 2023, respectively.
The increase in gross profit was partly supported by decreased depreciation as well as continued initiatives aimed at optimizing manufacturing processes. Included in the gross profit was depreciation of $1,519,439 and $1,830,553 for the years ended December 31, 2025, and 2024, respectively.
The increase was mainly driven by the equity raise, generating net proceeds of $9,922,063 from the issuance of common stock and prefunded warrants, partly offset by the repayment of lease agreements in connection with the sales of production equipment in Ballerup as mentioned above. 2024 2023 Net Cash Used in Operating Activities $ (7,534,072 ) $ (4,183,918 ) Net Cash Used in Investing Activities (424,036 ) (2,886,036 ) Net Cash Provided by Financing Activities 8,493,300 580,645 Net Change in Cash and Cash Equivalents 446,547 (6,175,190 ) Cash and Cash Equivalents at End of Period $ 10,868,728 $ 10,422,181 Off-Balance Sheet Arrangements As of December 31, 2024, we had no off-balance sheet arrangements.
The decrease was mainly driven by the equity raise, generating net proceeds of $9,922,063 from the issuance of common stock and prefunded warrants in 2024. 2025 2024 Net Cash Used in Operating Activities $ (6,108,176 ) $ (7,534,072 ) Net Cash Used in Investing Activities (217,930 ) (424,036 ) Net Cash Provided by Financing Activities 722,005 8,493,300 Net Change in Cash and Cash Equivalents (5,798,343 ) 446,547 Cash and Cash Equivalents at End of Period $ 5,070,385 $ 10,868,728 Off-Balance Sheet Arrangements As of December 31, 2025, we had no off-balance sheet arrangements.
Part of the invoicing to the customer is also attributed to the commissioning, and at transfer of the control of the system (i.e., the first performance obligation), this portion is recognized as contract liabilities. 29 Table of Contents Aftermarket sales represent parts, extended warranties, and maintenance services.
This second performance obligation is recognized as revenue at the time of the commissioning services being rendered together with the cost incurred. Part of the invoicing to the customer is also attributed to the commissioning, and at transfer of the control of the system (i.e., the first performance obligation), this portion is recognized as contract liabilities.
The cash used by operating activities for the year ended December 31, 2024, consists mainly of the net loss for the year of $(10,345,258) adjusted by depreciation and other non-cash items of $4,432,671.
The cash used by operating activities for the year ended December 31, 2025, consists mainly of the net loss for the year which improved by $1,743,318, adjusted by depreciation and other non-cash items of which decreased $657,120.
Cash provided by financing activities was $8,493,300 for the year ended December 31, 2024, as compared to $580,645 for the year ended December 31, 2023, representing an increase of $7,912,655.
Cash provided by financing activities was $719,287 for the year ended December 31, 2025, as compared to $8,493,300 for the year ended December 31, 2024, representing a decrease of $7,774,013 or 92%.
Cash used by operating activities for the year ended December 31, 2024, was $7,534,072 compared to cash used by operating activities of $4,183,918 for the year ended December 31, 2023, representing an increase of $3,350,154.
Cash used by operating activities for the year ended December 31, 2025, was $6,108,176 compared to cash used by operating activities of $7,534,072 for the year ended December 31, 2024, representing an improvement of $1,425,896.
Long-Lived Assets The Company assesses the impairment of long-lived assets when events or changes in circumstances indicate that the carrying value of the assets or the asset grouping may not be recoverable.
Inventory valuation adjustments for excess and obsolete inventories are calculated based on current inventories levels, movement, expected useful lives, and estimated future demand for our products. Long-Lived Assets The Company assesses the impairment of long-lived assets when events or changes in circumstances indicate that the carrying value of the assets or the asset grouping may not be recoverable.
General and administrative expenses for the year ended December 31, 2024, were $5,661,455 compared to $4,856,779 for the same period in 2023, representing an increase of $804,676, or 16.6%.
Costs for outbound distribution, including tariffs, and expenditures related to external sales consultancy services also increased in 2025. General and administrative expenses for the year ended December 31, 2025, were $5,677,525 compared to $5,661,455 for the same period in 2024, representing an increase of $16,070, or 0.3%.
This decline in gross profit can be attributed to the decrease in revenue, resulting in lower overall activity levels and underutilization of our manufacturing capacity, as well as an unfavorable sales mix, which resulted in a lower proportion of high-margin products such as liquid filtration systems and ceramic membranes.
This increase in gross profit can be attributed to both an increase in revenue as well as a more favorable sales mix, which resulted in a higher proportion of high-margin products within our Systems segment.
The decline was mainly due to reduced deliveries of liquid filtration systems, plastics products, ceramic membranes, and aftermarket sales, partly offset by increased sales of DPFs. The decrease in deliveries of liquid filtration systems was mainly driven by reduced deliveries of pool filtration systems and marine scrubber systems.
The increase was mainly due to increased deliveries of systems (Pool, Energy & Industry), and components (plastics), partly offset by decreased sales of filters. The increase in deliveries of systems was mainly driven by increased deliveries of pool filtration systems and water treatment systems for industrial applications.
This typically occurs upon shipment of the system from the production facility but can also occur upon other agreed delivery terms.
System sales are recognized when the Company transfers control to the customer based upon sales and delivery conditions specified in the sales contract, or for larger projects in line with completion. This typically occurs upon shipment of the system from the production facility but can also occur upon other agreed delivery terms.
The increase was also partially attributable to the release of bonus provisions in the comparable period of 2023. Included in general and administrative expenses was non-cash compensation of $664,434 and $627,904 for the years ended December 31, 2024, and 2023, respectively.
The increase was primarily due to higher legal expenses, the filling of open positions, including the CFO, as well as higher recruitment costs. Included in general and administrative expenses was non-cash compensation of $987,072 and $664,434 for the years ended December 31, 2025, and 2024, respectively.
Year Ended December 31, Period to Period Change As a % As a % Percent 2024 of Sales 2023 of Sales Variance % Revenue $ 14,604,618 100.0 % $ 18,001,652 100.0 % $ (3,397,034 ) (18.9 )% Cost of goods sold 14,353,713 98.3 $ 15,226,176 84.6 (872,463 ) (5.7 ) Gross Profit 250,905 1.7 2,775,476 15.4 (2,524,571 ) (91.0 ) Operating Expenses Selling expenses 2,725,239 18.7 4,298,905 23.9 (1,573,666 ) (36.6 ) General and administrative expenses 5,661,455 38.8 4,856,779 27.0 804,676 16.6 Research and development expenses 1,352,060 9.3 1,418,842 7.9 (66,782 ) (4.7 ) Total Operating Expenses 9,738,754 66.7 10,574,526 58.7 (835,772 ) (7.9 ) Loss from Operation (9,487,849 ) (65.0 ) (7,799,050 ) (43.3 ) (1,688,799 ) 21.7 Other Income (Expense) Interest and other income 178,834 1.2 366,365 2.0 (187,531 ) (51.2 ) Interest expense (167,556 ) (1.1 ) (151,670 ) (0.8 ) (15,886 ) 10.5 Amortization of debt discount (615,552 ) (4.2 ) (400,903 ) (2.2 ) (214,649 ) 53.5 Gain (loss) on foreign currency transactions 164,310 1.1 (359,960 ) (2.0 ) 524,270 (145.6 ) Gain (loss) on disposal of property and equipment (456,282 ) (3.1 ) 7,254 0.0 (463,536 ) (6,390.1 ) Loss on assets held for sale - - (439,388 ) (2.4 ) 439,388 (100.0 ) Total Other Expense (896,246 ) (6.1 ) (978,302 ) (5.4 ) 82,056 (8.4 ) Loss Before Income Taxes (10,384,095 ) (71.1 ) (8,777,352 ) (48.8 ) (1,606,743 ) 18.3 Income Tax Benefit (38,837 ) (0.3 ) (206,207 ) (1.1 ) 167,370 (81.2 ) Net Loss $ (10,345,258 ) (70.8 )% $ (8,571,145 ) (47.6 )% $ (1,774,113 ) 20.7 % Revenues Revenue for the year ended December 31, 2024, was $14,604,618 compared to $18,001,652 for the same period in 2023, representing a decrease of $3,397,034, or 18.9%.
Year Ended December 31, Period to Period Change As a % As a % Percent 2025 of Sales 2024 of Sales Variance % Revenue $ 16,507,558 100.0 % $ 14,604,618 100.0 % $ 1,902,940 13.0 % Cost of goods sold 15,257,035 92.4 $ 14,353,713 98.3 903,322 6.3 Gross Profit 1,250,523 7.6 250,905 1.7 999,618 398.4 Operating Expenses Selling expenses 2,718,047 16.5 2,725,239 18.7 (7,192 ) (0.3 ) General and administrative expenses 5,677,525 34.4 5,661,455 38.8 16,070 0.3 Research and development expenses 1,163,651 7.0 1,352,060 9.3 (188,409 ) (13.9 ) Total Operating Expenses 9,559,223 57.9 9,738,754 66.7 (179,531 ) (1.8 ) Loss from Operation (8,308,700 ) (50.3 ) (9,487,849 ) (65.0 ) 1,179,149 (12.4 ) Other Income (Expense) Interest and other income 445,496 2.7 178,834 1.2 266,662 149.1 Interest and other expense (315,458 ) (1.9 ) (167,556 ) (1.1 ) (147,902 ) 88.3 Amortization of debt discount (426,982 ) (2.6 ) (615,552 ) (4.2 ) 188,570 (30.6 ) Gain (loss) on foreign currency transactions 67,917 0.4 164,310 1.1 (96,393 ) (58.7 ) Gain (loss) on disposal of property and equipment (65,667 ) (0.4 ) (456,282 ) (3.1 ) 390,615 (85.6 ) Total Other Expense (294,694 ) (1.8 ) (896,246 ) (6.1 ) 601,552 (67.1 ) Loss Before Income Taxes (8,603,394 ) (52.1 ) (10,384,095 ) (71.1 ) 1,780,701 (17.1 ) Income Tax Benefit (1,454 ) (0.0 ) (38,837 ) (0.3 ) 37,383 (96.3 ) Net Loss $ (8,601,940 ) (52.1 )% $ (10,345,258 ) (70.8 )% $ 1,743,318 (16.9 )% 15 Table of Contents Revenues Revenue for the year ended December 31, 2025, was $16,507,558 compared to $14,604,618 for the same period in 2024, representing an increase of $1,902,940, or 13.0%.
The increase in sales of DPFs was primarily driven by the effective execution of strategies designed to capitalize on the increased demand for DPFs. 24 Table of Contents Gross Profit Gross profit for the year ended December 31, 2024, was $250,905 (or a gross profit margin of 1.7%), compared to $2,775,476 (or a gross profit margin of 15.4%) for the same period in 2023, representing a decrease of $2,524,571, or approximately 91.0%.
Gross Profit Gross profit for the year ended December 31, 2025, was $1,250,523 (or a gross profit margin of 7.6%), compared to $250,905 (or a gross profit margin of 1.7%) for the same period in 2024, representing an increase of $999,618, or 398.4%.
This decrease in other expenses was partially offset by a non-cash loss related to the disposal of property and equipment, decreased interest income, and higher debt discount amortization costs due to the extension of the maturity date for the senior promissory notes, with additional warrants issued as consideration for the extension. 25 Table of Contents Income taxes provision The income tax benefit for the year ended December 31, 2024, was $38,837 compared to a benefit of $206,207 for the comparable period in 2023, representing a decrease of $167,370, or 81.2%, mainly driven by a decrease in tax credits associated with research and development activities in Denmark.
Income taxes provision The income tax benefit for the year ended December 31, 2025 , was $1,454 compared to a benefit of $38,837 for the comparable period in 2024 , representing a decrease of $37,383 , or 96.3% , mainly driven by a decrease in tax credits associated with research and development activities in Denmark.
Net Loss As a result of the cumulative effect of the factors described above, we had a net loss for the year ended December 31, 2024, of $10,345,258 compared to $8,571,145 for the comparable period in 2023, representing an increase in net loss of $1,774,113, or 20.7%.
Net Loss As a result of the cumulative effect of the factors described above, we reported a net loss for the year ended December 31, 2025, of $8,601,940 compared to $10,345,258 for the comparable period in 2024, representing an improvement in net loss of $1,743,318, or 16.9%. 16 Table of Contents Going Concern and Management’s Plans The financial statements included herein for the period ended December 31, 2025, have been prepared under the assumption that the Company will continue as a going concern and contemplate the realization of assets and settlement of liabilities in the normal course of business.
Operating Expenses Total operating expenses for the year ended December 31, 2024, were $9,738,754, representing a decrease of $835,772, or 7.9%, compared to $10,574,526 for the same period in 2023. Selling expenses for the year ended December 31, 2024, were $2,725,239, compared to $4,298,905 for the same period in 2023, representing a decrease of $1,573,666, or 36.6%.
Operating Expenses Total operating expenses for the year ended December 31, 2025, were $9,559,223, representing a decrease of $179,531, or 1.8%, compared to $9,738,754 for the same period in 2024. In local currency, the cost decrease was higher driven by a DKK/USD appreciation of 3.9% for the full year.
The decrease was primarily due to a more focused R&D strategy with fewer ongoing projects and a reduced average number of employees engaged in external research and development activities, as the Company streamlined and centralized its R&D function. This was partially offset by one-time exit costs associated with a loss-making external development project.
The decrease was primarily due to a more focused R&D strategy with fewer ongoing projects and a reduced average number of employees engaged in external research and development activities. Other income (expense) Total Other expense for the year ended December 31, 2025, was $294,694 compared to $896,246 for the comparable period in 2024, representing a decrease of $601,552, or 67.1%.
Most commonly, this invoice is sent to the customer at commissioning of the product or no later than 12 months after delivery. Further included in Contract Assets are short-term receivables such as VAT and other receivables.
Also included in Contract Assets are short-term receivables such as VAT and other receivables.